Shanghai ChemPartner, a group company of ShangPharma, and Sanwa Kagaku Kenkyusho, a pharmaceutical company headquartered in Nagoya, Japan, have entered into a strategic alliance.
Subscribe to our email newsletter
The partnership was formed as a key element of a strategic initiative for Sanwa Kagaku Kenkyusho (SKK) to target the Asian market, in step with SKK’s new medium-long term business plan and expanding presence in diabetic research.
Th alliance is expected to help SKK achieve its drug discovery goals. The business terms and details of this project were not disclosed.
Michael Hui, CEO of ChemPartner, said: “We are delighted to be entering this strategic alliance with SKK. We are proud and honored that SKK have selected ChemPartner to be one of their partners and we look forward to building a long and successful relationship between our two companies in the future.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.